Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
09/12/2025 14:08
Dec 9 (Reuters) - XBiotech Inc XBIT.O: XBIOTECH INC - JOHN SIMARD TO RETIRE AS CEO OF XBIOTECH - SEC FILING XBIOTECH INC - SUSHMA SHIVASWAMY APPOINTED INTERIM CEO OF XBIOTECH - SEC FILING XBIOTECH INC - JOHN SIMARD TO CONTINUE AS CHAIRMAN OF XBIOTECH - SEC FILING XBIOTECH - JOHN SIMARD TO RETIRE AS CEO; WILL CONTINUE TO SERVE AS CHAIRMAN OF BOARD OF DIRECTORS Source text: [ID:n0001171843-25-007836] Further company coverage: XBIT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke